Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EN5G | ISIN: SE0020388577 | Ticker-Symbol: J8P
Frankfurt
21.11.24
08:08 Uhr
1,700 Euro
+0,055
+3,34 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
CINCLUS PHARMA HOLDING AB Chart 1 Jahr
5-Tage-Chart
CINCLUS PHARMA HOLDING AB 5-Tage-Chart

Aktuelle News zur CINCLUS PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14.11.Cinclus Pharma Holding AB: Interim Report January - September 202441"The need for new alternatives to PPIs is evident as PCABs are making great progress worldwide," said Christer Ahlberg, CEO of Cinclus Pharma. Financial Summary, July - September 2024Net sales amounted...
► Artikel lesen
29.08.Cinclus Pharma Holding AB: Cinclus Pharma Interim Report April-June 202460Secured funding for continued development of linaprazan glurate "The highlight of the second quarter of the year was the listing of the company's shares on Nasdaq Stockholm. The listing means that...
► Artikel lesen
21.06.XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 21.06.2024249The following instruments on XETRA do have their first trading 21.06.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 21.06.2024 Aktien 1 US0097071007 Ajinomoto Co. Inc. ADR 2...
► Artikel lesen
CINCLUS PHARMA Aktie jetzt für 0€ handeln
20.06.TRILL IMPACT AB: Trading in Trill Impact's portfolio company Cinclus Pharma commences on Nasdaq Stockholm2
20.06.Nasdaq Stockholm welcomes Cinclus Pharma to the Main Market293Stockholm, Jun 20, 2024 - Nasdaq (Nasdaq: NDAQ) announces that trading in the shares of Cinclus Pharma Holding AB (ticker name: CINPHA) will commence today on the Nasdaq Stockholm Main Market. Cinclus...
► Artikel lesen
20.06.Cinclus Pharma Holding AB: First day of trading in Cinclus Pharma's ordinary shares on Nasdaq Stockholm231Cinclus Pharma Holding AB (publ) ("Cinclus Pharma" or the "Company"), a Swedish clinical stage pharmaceutical company, today announces the outcome of the offering of newly issued ordinary shares (the...
► Artikel lesen
19.06.Nasdaq Stockholm AB: Listing of Cinclus Pharma Holding AB on Nasdaq Stockholm214On request of Cinclus Pharma Holding AB, company registration number 559136-8765, Nasdaq Stockholm has admitted the company's shares to trading with effect from June 20, 2024. The decision is conditional...
► Artikel lesen
13.06.Nasdaq Stockholm AB: Listing of Cinclus Pharma Holding AB on Nasdaq Stockholm302Nasdaq Stockholm AB has assessed that Cinclus Pharma Holding AB, company registration number 559136-8765, fulfills Nasdaq Stockholm's listing requirements. Provided that Cinclus Pharma Holding AB applies...
► Artikel lesen
8 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1